Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Am J Transplant. 2011 Feb 7;11(3):561–567. doi: 10.1111/j.1600-6143.2010.03431.x

Table 2.

Odds ratios for the development of Primary Graft Dysfunction in logistic regression models

Model Odds Ratio per 15 ng/ml increase in [CC16] (95% CI) p-value
Unadjusted Base Model (n=103) 1.6 (1.03, 2.3) 0.03
Non-IPF only (n=67) 2.1 (1.2, 3.7) 0.01
IPF only (n=36) 1.1 (0.6–2.0) 0.7
Non-IPF Adjusted for:
 Cardiopulmonary Bypass (n=67) 2.0 (1.1, 3.6) 0.02
 Transplant Type (n=67) 2.1 (1.2, 3.8) 0.01
 Recipient Age (n=67) 2.0 (1.2, 3.6) 0.02
 Recipient Sex (n=67) 2.1 (1.2, 3.7) 0.01
 Recipient Race/Ethnicity (n=67) 1.9 (1.04, 3.5) 0.04
 Donor Age (n=60) 2.2 (1.2, 4.3) 0.01
 Donor Sex (n=65) 2.0 (1.1, 3.6) 0.02
 Donor Race/Ethnicity (n=64) 2.2 (1.2, 4.0) 0.01
 Total ischemic time (n=66) 2.1 (1.2, 3.9) 0.01
 PASP (n=66) 1.8 (1.0–3.4) 0.05
 Packed Red Blood Cells (n=43) 2.3 (1.1, 4.8) 0.02
 Platelets (n=47) 2.3 (1.2, 4.4) 0.02

Odds ratios for the development of Primary Graft Dysfunction in logistic regression models per 15 ng/ml increase in [CC16].

IPF = Idiopathic Pulmonary Fibrosis

PASP = Pulmonary Arterial Systolic Pressure

OR determined using 6 hour [CC16]